Total liabilities held-for-sale

  
Based on the agreement to sell, it was determined that the assets and liabilities of the Microbial Control business unit met the criteria to be presented as “held for sale." As a result, as of December 31, 2021, such assets and liabilities were classified as held for sale and are reported on the Consolidated Balance Sheets. The Company expects that the transaction will close for approximately $1.273 billion in the second quarter of 2022 and that the sale proceeds less costs to sell will exceed the carrying value of the net assets.Included in the Company's Consolidated Balance Sheets as of December 31, 2021 are the following carrying amounts of the assets and liabilities held for sale:

|  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |
| (DOLLARS IN MILLIONS) | December 31, 2021 |
| Assets |  |
| Trade receivables, net | $ | 63  |  |
| Inventories | 125  |  |
| Property, plant and equipment, net | 30  |  |
| Goodwill | 536  |  |
| Other intangible assets, net | 349  |  |
| Operating lease right-of-use assets | 5  |  |
| Other assets | 14  |  |
| Total assets held-for-sale | $ | 1,122  |  |
| Liabilities |  |
| Accounts payable | $ | 69  |  |
| Deferred tax liability | 24  |  |
| Other liabilities | 8  |  |
| Total liabilities held-for-sale | $ | 101  |  |

  
NOTE 23.   SUBSEQUENT EVENTSHealth Wright Products, LLC AcquisitionOn February 16, 2022, the Company announced that it had entered into an agreement to acquire Health Wright Products, LLC, a leader in formulation and capsule manufacturing for the dietary supplement industry. 108
